Body fat percentage was significantly different between the three-ounce juice group and placebo. This three-ounce group also experienced a significantly lower body mass index (BMI) score compared with placebo at eight weeks. The six-ounce group had significantly lower BMI than placebo at four weeks and at eight weeks.

Dr. Udani reports that no side effects or safety concerns emerged at any dosage tested, and cautions that longer studies with larger numbers of participants are needed to confirm the findings and further probe a possible dose-dependent effect. However, this first human clinical trial points to exciting avenues for XanGo Juice's use in the maintenance of heart health and other conditions that may be connected to inflammation.

Previous research shows the xanthonesin XanGo Juice may possess antioxidant and anti-inflammatory properties that may help sustain a healthy cardiovascular system, support cartilage and joint function, support the immune system, promote a healthy seasonal respiratory system, maintain intestinal health and neutralize free radicals.

Source: Publicis Consultants | PR